Express News | Beauty care Concept stocks continue to rise, SYoung Group and Jeya Group both increase by over 10%.
Express News | Fuerjia: Class III Medical Devices have completed the clinical trial filing.
Furiga (301371): Actively carry out channel product optimization and wait for the rebound in revenue performance.
Event description: The company released its 2024 annual report and the Q1 report for 2025. In 2024, the company achieved revenue of 2.02 billion yuan, a year-on-year increase of 4.3%; it realized a net income of 0.66 billion yuan, a year-on-year decline of 11.
A-shares have unusual movements丨Cosmetic stocks continue to be popular. Lafang China has achieved 4 limits in 6 days, and Shanghai Jahwa has risen over 6%.
On May 20, according to Gelonghui, A-share cosmetic stocks continue to be popular, among which Anhui Hyea Aromas surged 12%, Fugejia rose over 10%, and Lafang China achieved four board limits in six days. SYoung Group, Shanghai Jahwa United, and Marubi Biological also rose over 6%. According to reports, data shows that on the first day of the 618 shopping festival on Taobao, the GMV of beauty products reached 4.18 billion yuan, with a year-on-year increase of 14.3%. During the Tmall 618 promotion, the first round of battle reports for the "Hot Beauty Product Festival" in Li Jiaqi's live broadcast room showed that the GMV for added purchases in the first hour increased by over 10% compared to last year, with brands like Kefu Beauty and Proya Cosmetics selling over 600,000 pieces of domestic hot products in seconds. Relevant data shows that in recent years, the cosmetics industry through e-commerce channels has seen significant growth.
Express News | Ergothioneine has attracted attention, and many listed companies have responded to related questions.
Express News | Fuhua: The company currently has no technology for producing ergotamine.
The Concept of ergotamine has driven beauty care stations to a peak, beware of the risks of high-positioned collective stocks retreating.
Track the entire lifecycle of the main Sector.
Express News | Beauty care concept stocks have once again strengthened, with Lafang China hitting the limit up.
Firmer (301371): Revenue in 2024 increased by 4.3% year-on-year, with a focus on the progress of new products and channel optimization.
The company's performance for 2024 and Q1 2025 is below our expectations. The company announced its performance for 2024: revenue of 2.017 billion yuan, +4.3% year-on-year; net income attributable to shareholders of 0.661 billion yuan, year-on-year decrease.
Fuerjia (301371) 2024 annual report and 2025 first quarter report review: The adjustment of the Business structure and increased expense inputs have pressured performance, looking forward to a gradual improvement in Operation efficiency.
Event: In 2024, the revenue/net income attributable to the parent increased by 4.3%/-11.8% year-on-year, and in Q1 2025, it decreased by 26.4%/-39.8%. Fuhua Jia released the 2024 annual report and the 2025 Q1 report.
Furija (301371): The adjustment of channel structure continues, and the Global Strategy of "cosmetic machinery synergy" deepens.
The company announced its 2024 annual report and 2025 first quarter report: 2024 revenue of 2.017 billion yuan (up 4.3% year-on-year), net income attributable to the parent company of 0.661 billion yuan (down 11.8% year-on-year), less non-net income attributable to the parent company.
Furija (301371): Increased investment in marketing and promotion puts pressure on performance in Q1 2025.
Furja released its 2024 annual report and the first quarter report for 2025: the total revenue for 2024 is 2.017 billion yuan, +4.32% year-on-year; the net profit attributable to the parent company is 0.661 billion yuan, -11.77% year-on-year; the net profit attributable to the parent company after deduction is 6.0.
Shiyerjia (301371): Channel optimization and price adjustment have a short-term impact on growth.
Furja released its annual report, achieving revenue of 2.017 billion yuan in 2024 (yoy +4.32%), and net profit attributable to shareholders of 0.661 billion yuan (yoy -11.77%). Revenue for Q1 2025 was 0.301 billion yuan.
Schierjia: Report for the first quarter of 2025
Shiljia: 2024 Annual Report Summary
Shiljia: 2024 Annual Report
Shuerjia (301371.SZ): In 2024, the net income is 0.661 billion yuan, a year-on-year decrease of 11.77%.
On April 22, Gelonghui announced that Fuirujia (301371.SZ) released its annual report for 2024. During the reporting period, the company achieved revenue of 2.017 billion yuan; it realized a net income attributable to the shareholders of the listed company of 0.661 billion yuan, a year-on-year decrease of 11.77%. A cash dividend of 10 yuan will be distributed for every 10 shares to all shareholders, and a capitalization reserve will increase 3 shares for every 10 shares to all shareholders.
Express News | Filler Jia: In the first quarter of 2025, the net income was 91.3843 million yuan, a year-on-year decrease of 39.77%.
Fuhua (301371.SZ): Currently actively laying out the overseas market.
On April 16, Gelonghui reported that Fulejia (301371.SZ) stated on the investor interaction platform that the company is currently actively expanding into overseas markets.
A-shares in the Aesthetic Medicine Concept collectively strengthened, with Beitaini rising over 3%.
On April 15, according to Gelonghui, the A-share market saw a collective rise in medical beauty stocks. Among them, Jieya Co., Ltd. hit the limit of 20CM, Liuzhou Liangmianzhen reached 10CM, Marubi Biotechnology rose over 7%, Fulijia increased nearly 7%, Jiaheng Homecare and Lafang China rose over 4%, Winner Medical, Betaine, SYoung Group, and Chongqing Baiya Sanitary Products rose over 3%.